Mednet Logo
HomeNeurologyQuestion

How do you counsel patients who develop DVT or atrial fibrillation requiring anticoagulation when being treated with lecanemab or donanemab?

2
4 Answers
Mednet Member
Mednet Member
Neurology · Vanderbilt University Medical Center

I do not think that anticoagulation is contraindicated in patients with these Alzheimer's disease antibodies, but I would want to check APOE status. I would not initiate the AD treatment if the patient is E4E4, and even one E4 would make me hesitant to have a patient on anticoagulation and an Alzhei...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Neurology · HCA Houston Healthcare

I believe until further data/studies are available, I would prefer not to use anticoagulation (at least long term) without comprehensive discussion among other treating physicians depending on the indication. The lecanemab appropriate use recommendations (Cummings et al., PMID 37357276) recommend ag...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Neurology · Vanderbilt University Medical Center

I would do an MRI and APOE testing. If more than 2-3 microbleeds or other evidence of CAA, or APOE4, I would not treat with lecanemab, and certainly not with lecanemab and anticoagulation.

Register or Sign In to see full answer

Mednet Member
Mednet Member
Neurology · Vanderbilt University Medical Center

I would be concerned only with patients with E4 homozygous state.

Register or Sign In to see full answer